Augmedix

company

About

Delivers industry-leading, ambient medical documentation and data solutions for healthcare systems, hospitals, practices, and more.

  • 251 - 500

Details

Last Funding Type
Series B
Last Funding Money Raised
$19M
Industries
Electronic Health Record (EHR),Google Glass,Health Care,Hospital,Medical,Real Time
Founded date
Jan 1, 2012
Number Of Employee
251 - 500
Operating Status
Active

Augmedix (Nasdaq: AUGX) delivers industry-leading, ambient medical documentation and data solutions to healthcare systems, physician practices, hospitals, and telemedicine practitioners.

Augmedix is on a mission to help clinicians and patients form a human connection at the point of care without the intrusion of technology. Augmedix’s solutions extract data from natural physician-patient conversations and convert it to medical notes in real time, which are seamlessly transferred to the EHR. To achieve this, the company’s Ambient Automation Platform uses Automated Speech Recognition and Natural Language Processing, supported by medical documentation specialists.

Leveraging this platform, Augmedix’s solutions relieve clinicians of administrative burden, in turn, reducing burnout and increasing both clinician and patient satisfaction. Augmedix is also leading the revolution in leveraging point-of-care data by making connections between millions of physician-patient interactions and analyzing them to deliver actionable insights that elevate patient care.

Augmedix is headquartered in San Francisco, CA, with offices around the world. To learn more, visit www.augmedix.com.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$19M
Augmedix has raised a total of $19M in funding over 2 rounds. Their latest funding was raised on Oct 24, 2019 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 24, 2019 Series B $19M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Augmedix is funded by 1 investors. Gaingels are the most recent investors.
Investor Name Lead Investor Funding Round
Gaingels Series B